Vets Plus, Inc., the animal health company based in Wisconsin, USA, is currently in the news for acquiring Merrick’s, Inc., another animal feed manufacturer in the state, in a bid to expand its footprints across Wisconsin. Sources familiar with the development claim that the company has taken over Merrick’s that provides tablets, powders, electrolytes and boluses for livestock.
According to authentic sources, Merrick’s is expected to operate as a wholly-owned subsidiary with the name Merrick’s Animal Health, LLC under Vets Plus, that includes treats, supplements and Probios probiotics in its product array. Sources further affirm that the subsidiary will continue manufacturing and selling its range of products from the manufacturing plant at Wonewoc, Wisconsin. Its operations of sales and customer services will remain at the Middleton office and all employees of Merrick’s, along with its former CEO Johanna Kuehn and COO (Chief Operations Officer) Dan Shields, will continue to work with the new entity.
David Nelson, President of Vets Plus, commented on the latest move saying that the company is experiencing commendable growth and Merrick’s addition would prove highly profitable for the firm’s manufacturing potential and product offerings. The inclusion of the 66,000-square feet production as well as the warehouse space in the Wonewoc plant has added to more than 35,000 square feet of Vets Plus’s production. Nelson further noted that both Dr. Shields and Ms. Kuehn endow the company with customer relationships and extensive market and product knowledge, working efficiently with the Vets Plus team.
Vets Plus, for the record, is a leading producer of health and nutrition supplements for livestock as well as companion animals. The company has customers all across North America and develops custom formulations for new probiotics. It also runs a sales office in Germany serving Europe and Asia.
Vets Plus CEO, Rajiv Lall, revealed that the company is excited about expanding its offerings through this acquisition and Merrick’s customer and product portfolio are likely to complement and strengthen its existing business.
Financial terms of the transaction have not been disclosed yet.
